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ABSTRACT  The mouse pituitary cell line, AtT-20, packages the adrenocorticotropic  hormone 
(ACTH)  in  secretory vesicles  and  releases  it when the cell  is stimulated  with secretagogues. 
These  cells  have  the  capacity,  after  transfection  with  the  appropriate  DNA,  to  package 
heterologous peptide hormones into the regulated secretory vesicles  (Moore, H. P. H., M. D. 
Walker,  F.  Lee, and  R.  B.  Kelly,  1983,  Cell,  35:531-538).  To test  if other secreted  proteins 
prefer a different route to the surface,  we have transfected AtT-20 cells with DNAs coding for 
a fragment  of a membrane  protein,  the vesicular  stomatitis  virus  G  protein  from  which  the 
membrane  spanning domain  has been deleted  (Rose, J.  K., and J.  E.  Bergmann,  1982,  Cell, 
17:813-819).  We  found  that  the  secreted  vesicular  stomatitis  virus  G  proteins  were  not 
transported  to the regulated  secretory vesicles.  Instead  they preferentially  exited the cell  by 
the constitutive  pathway previously found  in these cells (Gumbiner, B., and R. B. Kelly,  1982, 
Cell,  28:51-59).  In contrast,  human growth  hormone transfected  into the cells  by the same 
procedure was transported to the regulated  pathway with a similar efficiency as the endoge- 
nous  hormone  ACTH.  Transport  of the  secreted  G  protein  to  the  regulated  pathway,  if  it 
occurs at all,  is at least  30-fold  less efficient  than  peptide  hormones.  We conclude  that the 
transport machinery in AtT-20 cells must selectively recognize different secreted proteins and 
sort them into distinct secretory pathways. 
Most  higher  eucaryotic cells  can  secrete  proteins  into  the 
extracellular space.  It has  been  known  for some time  that 
secretion from a  given cell  type can be either  regulated or 
constitutive (31).  Regulated secretory cells  store specialized 
secretory products at high concentrations in secretory vesicles, 
which accumulate in the cytoplasm until  exocytosis is trig- 
gered by a  stimulus.  In constitutively secreting  cells,  newly 
synthesized protein is not stored but leaves the Golgi appa- 
ratus in short-lived membrane vesicles that fuse immediately 
with the plasma membrane in the absence of  any extracellular 
signal.  In  both  types  of secretory  cell,  different  secretory 
proteins can be found in the same secretory vesicle.  It was 
therefore plausible  to suggest  that secreted  proteins are not 
segregated from one another in the Golgi apparatus (7). 
Segregation of secretory proteins needed to be reconsidered, 
however, when the constitutive and the regulated secretory 
pathways were found to co-exist in the same cell. The pituitary 
cell line, AtT-20, has a regulated pathway in which the adre- 
THE  JOURNAL OF  CELL BIOLOGY . VOLUME 101  November  1985  1773-1781 
© The Rockefeller University Press • 0021-9525/85/11/1773/09  $1.00 
nocorticotropic hormone (ACTH)  ~  precursor, proopiomelan- 
ocortin (POMC),  is  processed  to  mature  ACTH, stored  in 
regulated  secretory vesicles, and released  only when the cells 
are stimulated,  for example, with  8-Br-cAMP. The AtT-20 
cells use the constitutive pathway to externalize  a viral mem- 
brane glycoprotein (gp70)  made by these  cells (12). Further 
evidence that there are two routes to the surface in endocrine 
cells was obtained using inhibitors (10,  17). 
Although membrane proteins preferentially  take the con- 
stitutive  route to the surface, secreted proteins examined thus 
far appear to use  both pathways for externalization.  Some 
newly synthesized  hormones, for example,  did not enter the 
Abbreviations used in this paper. ACTH, adrenocorticotropic hor- 
mone; CAT, chloramphenicol acetyltransferase; Endo H, endogly- 
cosidase H; ER, endoplasmic reticulum; hGH, human growth hor- 
mone; POMC, proopiomelanocortin;  RIA, radioimmunoassay;  RSV- 
LTR, Rous sarcoma virus long terminal repeats; SV40, Simian virus 
40; TG, truncated G protein; VSV, vesicular stomatitis virus. 
1773 regulated pathway but were secreted by the constitutive path- 
way (12,  19).  Similarly, when AtT-20 cells were treated with 
drugs that elevated the synthesis ofglycosaminoglycans, these 
sugar chains were detectably secreted by both pathways (2). 
One possibility consistent with the earlier proposal that secre- 
tory proteins are not segregated, is that secreted proteins show 
no preference for one pathway over another. In such a passive 
situation, the amount entering each pathway is proportional 
to the bulk-flow into each pathway. A  second possibility is 
that sorting does exist but that the preference for one pathway 
over another is not absolute.  Sorting in  this case might be 
carrier-mediated  and  involve  sorting  domains  of the  type 
suggested by Blobel (1). 
If protein secretion is passive in AtT-20 cells, all proteins 
should partition equally between the two pathways.  In this 
report we present data that are difficult to reconcile with such 
a passive-flow model. A quantitative comparison of the secre- 
tion  of two  proteins  revealed  that  partition  into  the  two 
pathways can be different. Using an approach used to study 
proinsulin processing in AtT-20 cells (19), we have transfected 
AtT-20 cells with DNA sequences encoding a secreted form 
of the vesicular stomatitis virus (VSV) membrane G protein, 
from which the transmembrane and the cytoplasmic domains 
have been deleted (24). We found that the secreted G protein, 
unlike ACTH, is transported preferentially to the constitutive 
pathway, a result not readily explained if transport of secreted 
proteins  occurs  by  bulk-flow.  In  contrast,  human  growth 
hormone (hGH) transfected into these cells is sorted into the 
regulated pathway at least as efficiently as is the endogenous 
hormone,  ACTH.  We  conclude  that  transport  of proteins 
from the Golgi apparatus cannot be passive in these cells, but 
most likely involves a  cartier-mediated  sorting  mechanism 
that shows at least a 30-fold selectivity for different proteins. 
MATERIALS  AND  METHODS 
Antisera, Peptide Hormones, 
and Radioimmunoassays 
Rabbit serum against inactivated VSV (Indiana strain) was a generous gift 
of Dr. J. Rose.  Goat anti-hGH antiserum used for immunoprecipitation was 
obtained from Antibodies Inc. (Davis, CA). Affinity-purified rabbit anti-ACTH 
antibodies  were  generated  and  purified  as  described  previously  (18).  hGH 
purified from E. coli was a gift of Dr. Peter Seeburg. Synthetic ACTH peptide 
(1---~24) was from Organon Diagnostics (West Orange, N J). Radioimmunoassay 
(RIA) of ACTH was performed as described ( i 1). hGH RIA kits were purchased 
from Hybritech Inc. (La Jolla, CA). 
Recombinant Vectors 
The mammalian expression vector, pSV2-TG, carrying a truncated VSV O 
coding sequence downstream from the SV40 early promoter was a  generous 
gift of Dr. Jack Rose.  To construct a vector suitable for expression in AtT-20 
cells. 5 gg of this plasmid was digested with the restriction endonucleases PvulI 
and HindIlI (New England Biolabs, Beverly, MA), followed by treatment with 
calf intestinal phosphatase (Boehringer Mannheim Biochemicals, Indianapolis, 
IN) to remove the 5'  phosphates (16).  The enzymes were then removed from 
the  reaction  mixture  by  phenol-chloroform  extraction,  and  the  DNA  was 
recovered  by  ethanol  precipitation.  100  ng  of the  digested  vector was then 
ligated to 100 ng of a 398-bp NruI-HindIlI restriction fragment, which has been 
excised from the plasmid pRSV-CAT (9) and purified on a  1% agarose gel. The 
ligated mixture was used to transform E. coli strain BHl01,  and the plasmids 
from resulting ampicillin-resistant colonies were screened for the correct insert. 
The  plasmid  pKl3  carrying the hGH  gene was obtained  from  Dr.  Peter 
Kushner and Dr. Howard Goodman. Chloramphenicol acetyltransferase (CAT) 
constructs used for the comparison of promoter activities were from Dr. Don 
DeFranco (mouse  mammary tumor virus),  Dr. Thomas Edlund (herpes thy- 
midine kinase), and Dr. Cori Gorman (Rous sarcoma virus and Simian virus 
40 [SV40]). 
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DNA Transfection and Isolation of 
Stable Transformants 
AtT-20 cells were transfected with plasmid DNAs by the calcium phosphate 
procedure as described previously (19).  For transient expression,  100  ~g of 
uncut plasmid was used per 10-cm dish of cells. For stable transformants each 
dish received 120 ~g of nonselectable DNAs and 24 ~g of the selectable DNA, 
pSV2-neo. The antibiotic G418 (Geneticin) used for selection was from Gibeo 
Laboratories (Grand Island, NY). Clones were screened by RIA (for hGH) or 
by immunoprecipitation (for truncated  G  [TG]).  CAT  activity was assayed 
according to the procedure described by Walker et al. (32),  except that acetyl- 
CoA was added at a ten times higher concentration and the reaction was carried 
out longer (16 h). Spots from the thin layer plates were cut out and counted in 
a liquid scintillation counter, or alternatively, the autoradiogram was scanned 
to yield the numbers shown in Table I. 
Metabolic Labeling and Immunoprecipitation 
Cells grown  on  polylysine-coated dishes were first incubated in  medium 
lacking methionine for 30  min before labeling. 0.5  mCi  [~Slmethionine in 
medium containing  1/20th of the normal amount of methionine and 2.5% 
fetal calf serum was then added to each 10-cm dish for lengths of time indicated 
in the figure legends. Chase was carried out in  medium containing normal 
amounts  of  unlabeled  methionine  plus  2.5%  fetal  calf serum.  Ceils were 
harvested and prepared for immunoprecipitation according to the procedure 
of Rose and Bergmann (24).  Medium samples were lyophilized and dissolved 
in NDETS buffer (t%  Nonidet P-40, 0.4% deoxycholate, 66 mM  EDTA,  10 
mM  Tris,  pH  7.4,  and 0.3%  SDS).  For immunoprecipitation, samples were 
preadsorbed with fixed Staphylococcus  aureus cells (Pansorbin, Behring Diag- 
nostics, San Diego, CA) for 10 rain. The supernatant was then recovered and 
reacted to an excess of antiserum specific of VSV,  hGH, or ACTH (see next 
paragraph). After 2-3 h at room temperature, S.  aureus cells were added for 5 
min, and the suspension was layered on a  1 M  sucrose cushion in NDETS 
buffer. The cells were recovered by centrifugation, washed twice with NDETS 
buffer, rinsed once with distilled water, and boiled in SDS polyacrylamide gel 
sample buffer before electrophoresis. Endoglycosidase H (Endo H) digestion of 
immunoprecipitated materials was performed as described (24). 
Excess antisera were added to the antigen solutions to ensure the completion 
of the immunoprecipitation reactions. The amount of anti-hGH antiserum to 
be added was determined as follows. Each sample to be immunoprecipitated 
(cell lysate or medium) was first assayed by an RIA (Hybritech Inc.) specific 
for hGH to determine the amount of antigen present. The titer of the antiserum 
is then determined by adding increasing amounts of the serum to a  known 
concentration of the labeled antigen, followed by precipitation with S.  aureus 
cells and PAGE gel analysis. We found  1 /A of the antiserum is sufficient to 
precipitate  10 ng of hGH.  To ensure large excess we have used 5  ul of the 
antiserum to precipitate 10 ng of the antigen in these experiments. Anti-VSV 
antiserum was titrated similarly. That the immunoprecipitation reaction was 
indeed complete was further verified by keeping the antiserum constant at the 
excess level,  while doubling the  amount  of VSV  TG  present.  A  1.85-fold 
increase in radioactivity was specifically precipitated. 
Calculation of Rate Constants and Sorting Index 
RATE  CONSTANTS  FOR  ENDOPLASMIC  RET1CULUM  (ER)  AND 
GOLGI  EXPORT:  TO determine if the slow secretion of the TG protein is 
due to a slow transfer from ER to Golgi apparatus or from Golgi apparatus to 
cell surface, we compared its rate constants to those obtained for a constitutively 
secreted marker, POMC. To calculate rate constants of protein export from the 
ER (kE) and the Golgi apparatus (kc), we measured the steady-state pool sizes 
of these compartments. Since at steady-state there is a constant flux through 
all compartments, the rate of secretion equals the rate of ER export (kEIE]), 
which equals the rate of Golgi export (kG[G]). [E] and [G] are the concentrations 
in the ER and the Golgi apparatus, respectively. The rate constants can therefore 
be calculated as 
kE =  rate of secretion/[E]  (Eq. 1) 
kG =  rate of secretion/[G]. 
SORTING  INDEX:  The peptide hormones do not all enter the regulated 
pathway, presumably because sorting is not perfect in these cells. It is more 
appropriate to think of the partitioning between the two pathways in terms of 
a sorting ratio. From the simple model presented in Fig. 6, the fractional sorting 
ratio of peptide hormones into regulated secretory vesicles would be k,t/(kr~  + 
k¢0. This cannot be measured directly. What we have used instead is a sorting index that is the ratio of the increment in the release  rate when the cells are 
stimulated with 8-Br-cAMP (D) to the total rate of release  in the absence of 
stimulation (X). 
The sorting index D/X can be shown to be proportional to the fractional 
sorting ratio. The fractional sorting ratio is the fraction of the flux out of the 
Golgi apparatus that enters regulated secretory vesicles k,,[G]/(kr~ + k~0[G]. In 
the steady-state the denominator is the same as X, the measurable total flow 
out of the cell,  and the numerator is equal to ka[R], since the flux out of the 
secretory vesicles must be equal to the flux in. [R] cannot always be measured 
directly,  but the magnitude of [R] should affect  the increment in the release 
rate on stimulation D. If stimulation causes k,2 to increase by k,2*, then D  = 
kr2*[g].  The fractional  sorting ratio  is therefore (kr2/kr2*)D/X. Since k,2/k,2* 
should  be  a  constant,  the  fractional  sorting ratio  is linearly  related  to  the 
measurable ratio D/X.  We have therefore used the ratio D/X in our measure- 
ments. It should be greater than the true sorting ratio. 
The increased rate of release  D is in turn obtained by subtracting the rate of 
release in the absence of stimulation (PO from the stimulated total. The amount 
released in the absence of stimulation (X) is k,:~[R] +  k~[q (Fig.  6),  which 
equals at steady-state (k,~ + kc0[G]. D is k,2*[R]. The stimulated to unstimulated 
ratio is therefore [ka*[R]/(k,~ + k~)[G]] +  1. To enhance this ratio we can take 
advantage of the different time constants of the Golgi pool and the regulated 
secretory vesicle pool. By labeling and then chasing for a period equal to several 
times  the  Golgi  pool  half-life,  the  increment  on  stimulation  can  then  be 
measured with much higher accuracy.  If the time constant of the regulated 
pool is r, then the measured release  D'  =  D.e  -t/" and the fractional  sorting 
ratio becomes 
(k,2/k,2*. e-t/')D'/X.  (Eq. 2) 
Thus, the measured sorting index must be corrected for time. 
RESULTS 
Expression of a Secreted VSV G Protein and hGH 
in AtT-20 Cells by DNA Transfection 
To examine if different secreted proteins can take different 
routes to the cell surface, we chose to transfect AtT-20 cells 
with two cloned DNAs, each coding for a  secreted protein 
from a distinct origin. One, hGH, is normally secreted in a 
regulated manner by somatotrophs in the anterior pituitary. 
The other protein, in contrast, is not a product of endocrine 
cells but is of viral origin. It has been engineered in vitro by 
Rose and Bergmann (24)  by deleting the membrane-anchor 
domain  from the  VSV  membrane G  protein.  The  altered 
protein, containing an intact luminal region of the G protein 
(432  amino acids  from the  NH2-terminus) but  lacking the 
entire membrane-spanning and the cytoplasmic domains (79 
amino acids from the COOH-terminus), has been shown to 
be secreted from transfected COS cells and the  mouse cell 
C127 (8, 24). 
Fig.  1 A illustrates the construction of the plasmid vector 
used for expression of VSV TG protein in AtT-20 cells.  We 
found  that  the  vector pSV2-TG,  originally  constructed  by 
Rose and colleagues (24), failed to yield positive stable trans- 
formants at a reasonable frequency when co-transfected with 
the selectable DNA pSV2-neo (28).  This plasmid carries the 
VSV  TG sequences downstream from the SV40 early pro- 
moter. To improve the number of  clones expressing detectable 
levels of the  VSV  TG  protein,  we  surveyed a  number of 
cloned promoters for their ability to produce high levels of 
protein  expression in  AtT-20 cells.  Table I  compares CAT 
activities expressed transiently  from  various  promoter ele- 
ments. The highest level of expression was obtained with the 
Rous sarcoma virus long terminal repeat (RSV-LTR), which 
is two orders of magnitude more efficient in supporting CAT 
expression  in  these  cells than  is the  SV40  early promoter. 
Mouse  mammary tumor  virus  and  the  herpes  thymidine 
kinase  promoters yielded intermediate  levels.  We therefore 
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FIGURE  1  (A)  Construction  of an  RSV-LTR-containing  vector  for 
the expression of truncated  VSV (3  protein. The vector,  pSV2-TG, 
was obtained from I. Rose and contains the truncated VSV G  cDNA 
(1) downstream from the SV40 early promoter (Ira). The G  coding 
sequences are followed  by the SV40 t-antigen  splice junction  and 
the early region polyadenylation site (~), which also supply a stop 
codon near the end of the TG sequence (25). The pBR322 sequence 
contains the origin of replication and the ampicillin resistance gene 
(  ). To replace the SV40 promoter region with sequences from 
the RSV-LTR, pSV2-TG was digested with the restriction  endonu- 
cleases Pvull and Hindlll. The phosphatase-treated vector was then 
ligated to a gel-purified NruI-Hindlll fragment  (~.z~) containing  the 
RSV promoter activity. The latter was excised from  an  RSV-LTR- 
containing  plasmid driving the CAT gene (r~) (pRSV-CAT, 9). The 
resulting  plasmid,  pRSV-TG, carries a TG sequence joined to the 
RSV-LTR. All the other elements essential for expression remain the 
same as the parent  vector,  pSV2-TG. (B) Plasmid vector used for 
the expression of hGH.  pK13 contains  the 2.6-kb  hGH  gene (4) 
inserted  at  the  unique  EcoRI site  of  the  vector,  pSV2-gpt (20; 
Kushner, P., unpublished  observations). (I)  hGH  sequences; (r-n) 
Ecogpt (E. coil gene encoding  the enzyme xanthine-guanine  phos- 
phoribosyl  transferase) sequences. All the other sequences are the 
same as denoted in A. Also indicated  is the structure  of the hGH 
gene as reported  in reference  4 showing the position  of the four 
introns  (A,  B,  C, and  D), exons (n),and an alternative splice  site 
(B').  (5'  ~za) and  (~  3') are the  5'  and  3'  untranslated  regions, 
respectively. 
replaced the SV40 promoter region of the pSV2-TG (PvulI- 
HindIII fragment) with a fragment of the RSV-LTR contain- 
ing the  promoter activity (NruI-HindIII; reference  15)  (see 
Fig.  1 A). After co-transfecting AtT-20 cells with this plasmid 
and the selectable DNA pSV2-neo (28),  positive transform- 
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Promotor driving non- 
selectable DNAs 
Frequency of stable 
co-transmants ex- 
CAT activities  pressing detectable 
transiently ex-  levels of nonselect- 
pressed*  able markers 
% 
SV40 early  1  0.5 
TK  56  -- 
MMTV  51  -- 
RSV-LTR  244  66-75 
AtT-20 cells were transfected with plasmid  vectors containing various pro- 
motor  elements  fused  to  the CAT  gene.  Indicated  are the  levels  of CAT 
activities  expressed  in  the  cells  at  65  h  after  transfection.  Numbers  are 
normalized  to  the  activity from  the  SV40  early  promoter.  Right  column: 
cells  were  co-transfected  with  the  selectable  gene  neo  driven  from  the 
SV40 early promoter (pSV2-neo, 28) and a nonselectable DNA (VSV TG  or 
human proinsulin) fused to the promoter indicated.  The ratio of selectable 
DNA  to  nonselectable  DNA  was  1:5.  After  selection  with  the  antibiotic 
G418,  the survival  clones  were  scored  and  compared  to  the  number  of 
isolates  expressing  detectable  levels  of  the  nonselectable  markers.  TK, 
thymidine kinase.  MMTV, mouse mammary tumor virus. 
* Arbitrary units. 
ants were detected at a  frequency that is at least  10-20-fold 
higher than the SV40-derived vectors (Table I). 
To generate stable cell lines expressing hGH, we obtained 
a  plasmid,  pK13,  carrying the  hGH  gene  from  Dr.  Peter 
Kushner and Dr. Howard Goodman. This plasmid (Fig.  1 B) 
contains a complete hGH gene and its 5' flanking sequences 
on  a  2.6-kb  EcoRI  fragment  (4),  which  is  inserted  at  the 
EcoRI site of pSV2-gpt (20).  Preliminary experiments deter- 
mined that there is a  secondary toxic effect of the selection 
medium on AtT-20 cells (Burgess,  T., unpublished observa- 
tions),  therefore  we  did  not  use  the  Ecogpt  gene  on  this 
plasmid as a selectable marker. Instead, it was co-transfected 
with pSV2-neo (28),  and selection was carried out with the 
antibiotic G418. Approximately 25 % of the surviving clones 
expressed detectable levels of hGH as determined by RIA. 
VSV TG Protein and hGH Are Secreted into the 
Extracellular Medium by Transformed ArT- 
20 Cells 
Two  stable  transformants,  AtT-20-TG17  and  AtT-20- 
GH 13/5/4, expressing the VSV TG protein and hGH, respec- 
tively, were analyzed in  detail.  Synthesis of TG protein  in 
TG17  cells  was  demonstrated  by  immunoprecipitation  of 
metabolically labeled cells with an antiserum raised against 
inactivated VSV. In cells infected with VSV, the G protein is 
normally  synthesized  as  a  single  polypeptide with  two  N- 
linked  oligosaccharide  chains  (5,  22,  25)  and  one  or  two 
molecules of esterified fatty acids (26).  In the TG, the acyla- 
tion site has been eliminated but the glycosylation sites remain 
intact (24). TG 17 cells synthesize two differently glycosylated 
forms of the TG protein (Fig.  2  A, lane 1) which are absent 
from untransformed cells (Fig. 2A, lane 3). The predominant 
band  has a  mobility that  corresponds to  TG bearing high- 
mannose type carbohydrates. A minor, slower migrating band 
was also visible in  the cell extract which  corresonds to TG 
with complex type sugars.  The identity of these immunopre- 
cipitated bands was further confirmed by Endo H  digestion, 
which  cleaves  only  N-linked  oligosaccharides  of the  high 
mannose  type (23).  Treatment with  Endo  H  increases the 
mobility of the faster migrating band, while the mobility of 
FIGURE  2  Synthesis and secretion of (A) TG protein and (B)  hGH 
by  transformed  AtT-20  cells.  (A)  TG17  or  untransformed  AtT-20 
cells were radiolabeled with [3SS]methionine for 6 h and chased for 
3  h  in unlabeled medium. Cell extract and medium samples were 
immunoprecipitated separately  with  an  anti-VSV  antiserum,  and 
half of the  immunoprecipitates were subjected  to digestion with 
the  Endo  H.  The  labeled proteins were then  analyzed on  a  15% 
SDS polyacrylamide gel and visualized by autoradiography. Lanes 
1, 2, and 3, cell extract samples harvested at the end of the labeling 
period.  Lanes  4,  5,  and  6,  medium samples collected  during the 
chase.  Lanes  1,  2,  4,  and  5  are  immunoprecipitated  from  the 
transformed TG17 cells, and lanes 3 and 6 are from control AtT-20 
cells.  Endo H  digestion was only performed on samples shown in 
lanes 2  and  5.  Arrows  indicate  where the  native VSV  G  protein 
would migrate on these gels. R and S, Endo H-resistant and sensitive 
forms  of the  TG  protein,  respectively. (B)  GH13/5/4  and  control 
AtT-20 cells were labeled and chased as in A.  Extract (lanes  1,  2, 
and 3) or medium (lanes 4, 5, and 6) samples were immunoprecip- 
itated with a goat anti-hGH antiserum either in the absence (lanes 
1, 3, 4, and 6) or presence (lanes 2 and 5) of excess unlabeled hGH. 
Immunoprecipitates  were  analyzed  on  a  10-18%  gradient  SDS 
polyacrylamide gel. Lanes  1, 2, 4, and 5, samples from  GH13/5/4 
cells,  and  lanes 3  and  6  from  control  cells.  Arrows  indicate  the 
electrophoretic  position  of  hGH  purified  from  E. coli harboring 
hGH cDNA.  The faint band immediately above the 25-kD band is 
a contaminant in the immunoprecipitates. 
the slower migrating band remains the same (Fig.  2  A, lane 
2).  The majority of TG in the transfected cells is thus Endo 
H sensitive. 
TG17  cells  also  secrete  the  TG  into  the  tissue  culture 
medium (Fig.  2  A,  lane 4).  The secreted form contains the 
complex type carbohydrates, as evidenced by its resistance to 
Endo H  digestion (Fig.  2  A, lane 5).  A similar glycosylation 
pattern has been shown to occur with the endogenous hor- 
mone  ACTH  (12;  data  not  shown).  The  majority  of the 
precursor ACTH in the cell extract exists in the high mannose 
form, indicative of its ER and early Golgi localization. The 
secreted form, on the other hand, has acquired complex type 
sugars.  Thus the secreted TG protein appears to traverse the 
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ments before reaching the cell surface. Similar observations 
have been made with C127 cells (24). 
The clone, GH 13/5/4, synthesizes three growth hormone- 
related  polypeptides that  can  be  immunoprecipitated from 
the cell extract with an antiserum against hGH (Fig. 2  B, lane 
1).  All  three species were specifically precipitated as judged 
by two criteria.  First,  they were detected  only in  cells that 
were  transformed  with  the  hGH  gene  (compare  Fig.  2  B, 
lanes  1  and  3).  Second,  the  reaction with the  antiserum is 
abolished by the presence of  excess unlabeled growth hormone 
(Fig.  2  B, lane 2). The major species has a mobility on SDS 
polyacrylamide gels of 22 kD and co-migrates with authentic 
hGH. The two minor species have apparent molecular weights 
of 25  and  20  kD.  The  20-kD  protein  has  been  reported 
previously  to  be  synthesized  from  an  alternatively  spliced 
mRNA  (4;  see  Fig.  1 B,  legend),  and  has  been  found  in 
normal pituitary (13). It is synthesized in a variety of cell lines 
including GH3 and L-cells transfected with the 2.6-kb EcoRI 
hGH gene (Garcia, P., unpublished observations). The origin 
of the 25-kD species, however, is unclear. It is only found in 
this cell line but not in other lines (GH3 or L-cells) similarly 
transfected with the hGH gene, and may be due to an aberrant 
splicing or rearrangement event in this isolate. Unlike the TG 
and POMC, growth hormone does not undergo posttransla- 
tional glycosylation or proteolytic processing. Upon secretion, 
the same three polypeptide species were found in the medium 
(Fig. 2  B, lanes 4, 5, and 6). 
Secretagogues Accelerate the Release of hGH- 
Related Peptides but Do Not Affect the Apparent 
Rate of Secretion of the TG Protein 
The above data demonstrate that growth hormone and TG 
protein can be secreted from the transformed cell  lines, but 
do  not  identify  the  secretory pathways by which  they are 
externalized.  Previously work has shown that the two secre- 
tory pathways can be distinguished by secretagogues, which 
enhance secretion from only the regulated pathway (12,  18). 
We  therefore  determined  the  effect of 8-Br-cAMP  on  the 
secretion of hGH and the TG protein. 
TG17 and GH13/5/4 cells were metabolically labeled with 
[35S]methionine  for  6  h  and  chased  for  3  h  either  in  the 
presence or absence of 5 mM 8-Br-cAMP. Medium samples 
and  cell  extracts were collected separately, immunoprecipi- 
tated with specific antisera, and analyzed on SDS polyacryt- 
amide  gels  (Fig.  3).  Inclusion  of 8-Br-cAMP  in  the  chase 
period  caused  a  3-4-fold  increase  in  the  accumulation  of 
labeled hGH in  the  medium  of GH13/5/4  cells (Fig.  3  B, 
lanes  1  and  3).  This  is  accompanied  by  a  corresponding 
decrease of labeled hormone remaining in  the  cell extracts 
(Fig.  3  B,  lanes 5  and  7).  In marked contrast,  secretion of 
labeled TG protein from TG17 is not detectably affected by 
the same secretagogue (Fig.  3  A). The same amount of Endo 
H-resistant  form of the  TG  protein  was  recovered in  the 
medium regardless of whether 8-Br-cAMP was present (Fig. 
3  A,  lanes  1-4).  Furthermore,  cells that  have been treated 
with 8-Br-cAMP are not depleted of their intracellular pool 
of TG. Essentially the same levels of Endo  H-resistant and 
sensitive  forms  of the  TG  protein  were  recovered  in  the 
stimulated or unstimulated cells (Fig.  3  A, lanes 5-8).  Note 
that even after a chase period, the majority of the intracellular 
FIGURE  3  Effect of secretagogues on the secretion of (A) the TG 
protein and (B) hGH.  (A) TG17 cells were labeled with [35S]methi- 
onine  for 6  h  and then  chased for  3  h  either  in the  presence or 
absence of 5  mM 8-Br-cAMP.  Labeled materials released into the 
chase  medium and  those  remaining in  the  cells were  recovered 
and  immunoprecipitated  with  anti-VSV  antibodies.  Half  of  the 
immunoprecipitates were digested with  Endo H  and analyzed on 
SDS polyacrylamide gels along with the undigested materials. Lanes 
1 and 2, medium samples from unstimulated cells, and lanes 3 and 
4, from 8-Br-cAMP treated cells. Lanes 5 and 6, labeled molecules 
remaining in cells that have not been stimulated, and lanes 7 and 
8,  in cells that have been stimulated. Samples in lanes 2, 4,  6, and 
8 were digested with Endo H, whereas those in lanes 1, 3, 5, and 7 
were not. (B) GH13/5/4  cells were labeled and chased as in A and 
processed with anti-hGH antibodies. Lanes  I and 2, 3 and 4, 5 and 
6, and 7 and 8 are media of unstimulated cells, media of stimulated 
cells, extracts of unstimulated cells, and extracts of stimulated cells, 
respectively. Samples in lanes 2,  4,  6, and 8 were immunoprecipi- 
tared in the presence of excess of unlabeled hGH.  Note that lanes 
4  and 5  of  Fig.  2  B and  lanes  1 and  2  of  Fig.  3  B  represent the 
same gel. 
TG is Endo H sensitive. 
The apparent lack of stimulation of secretion of TG 17 cells 
is  not  due  to  their  inability  to  respond  to  secretagogues. 
Aliquots of the medium and cell extract samples used for the 
above analysis were  subjected to  RIAs for the  endogenous 
hormone,  ACTH.  TG17  cells  responded to  8-Br-cAMP by 
secreting  threefold  more  immunoreactive  ACTH  into  the 
medium than unstimulated cells.  This degree of stimulation 
is comparable to those from the untransformed AtT-20 popu- 
lation (3.5-fold) and also from the growth hormone-produc- 
ing GH 13/5/4  cells (3.4-fold).  Interestingly, secretion of all 
three hGH-related peptides were stimulated to about the same 
extent (Fig. 3  B, lanes 1, 3, 5, and 7). We conclude that hGH 
and its related peptides are targeted, at least in  part, to the 
regulated secretory pathway in this heterologous system in a 
way similar to the endogenous hormone ACTH. By contrast, 
MOORE AND  KELLY Secretory  Protein  Targeting  1777 little or no VSV TG protein is detected exiting the cell via the 
regulated pathway. 
hGH and TG Protein Are Externalized at 
Distinct Rates 
A second diagnostic tool for distinguishing  the two path- 
ways is the kinetics of release. Proteins taking the constitutive 
route are transported directly to the cell exterior (t,/~ ~  30-40 
min, 12), whereas those secreted by the regulated pathway are 
stored inside  secretory granules before release (t,j~ -  7 h, data 
not shown).  If hGH and TG protein indeed exit the cell by 
the regulated  and the constitutive routes,  respectively,  then 
their release should follow these characteristic  kinetics. 
To measure the kinetics of secretion,  TG 17 and GH 13/5/4 
cells  were  labeled  with  [35S]methionine  for  15  h  and  then 
chased  for various lengths  of time.  At a  given  time  point, 
labeled  materials  in  the  medium  and  in  the  cells  were  re- 
covered and analyzed (Fig. 4). We found that the majority of 
hGH was secreted by GH 13/5/4 cells with a half-time (6.3 h) 
similar to that measured  for mature ACTH (7  h,  data not 
shown).  In comparison, TG protein existed from TG17 cells 
with much faster kinetics (t,/~ ~  1.5 h), indicative of its consti- 
tutive mode of secretion. 
Although the majority of  the hGH was stored intracellularly 
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FIGURE  4  Kinetics of secretion of the TG  protein and hGH. TG] 7 
or GH13/5/4 cells were labeled with [3SS]methionine for  16 h and 
chased for increasing lengths of time. At the time indicated, medium 
samples were collected and the cells were extracted with detergent. 
TG  protein  and  hGH  were  recovered  by  immunoprecipitation, 
electrophoresed on  SDS  polyacrylamide gels,  and  quantitated by 
scanning the autoradiograms. The percentage of total labeled pro- 
teins remaining inside the cells at each time point is calculated and 
plotted  as  a  function  of  the  length  of chase.  (A)  hGH;  (O)  TG. 
Secretion  of  the  TG  protein  showed  a  single  exponential decay 
with a rate constant of 0.46 h -1 (or t,/2  =  1.5 h). The majority of hGH 
was secreted with a rate constant of 0.11  h -1 (or t,/, =  6.3 h). 
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GH13/5/4 cells was secreted  more rapidly into the medium. 
The kinetic measurements in Fig. 4 revealed two components 
of  secretion. About 80% of  the labeled intracellular pool exited 
the cells at a slow rate (t,/2 ~  6.3 h) characteristic  of regulated 
secretion. The remaining 20%, however, was secreted at a rate 
approaching constitutive secretion. This apparent leakage into 
the constitutive pathway is  reminiscent  of the  secretion  of 
POMC  and  proinsulin.  Previously  we  have  also  observed 
rapid  secretion  of a  portion  of the  newly  synthesized  hor- 
mones (12,  19), except in these cases they are in the form of 
the unprocessed precursors (see Discussion). 
The TC Protein Is Transported out of the 
ER Slowly 
In the above studies we noted that although the kinetics of 
release for TG protein (t,/~ -  1.5 h) was much faster than what 
would be expected from the regulated pathway, it was consid- 
erably slower  than the externalization  of other constitutive 
proteins such as gp70 and POMC (t,j, ~  30 min). The differ- 
ence  was  not due  to  storage  in  secretory  vesicles but  to  a 
relatively  slow rate of export of TG protein from the rough 
ER.  To show this the rates  of export from the ER and the 
Golgi apparatus were calculated from the relative  size of the 
ER and the Golgi pools.  To measure the ER and Golgi pool 
sizes,  the  intracellular  amounts  of Endo  H-sensitive  and 
resistant  forms of the TG proteins were determined by im- 
munoprecipitation of steady-state  labeled cells and compared 
to the steady-state  rate  of secretion  (Table  II).  The rates  of 
export from the ER and the Golgi apparatus were calculated 
according to Eq. 1 (see Materials and Methods) and compared 
with those obtained for another constitutive marker, POMC. 
TG 17 cells exhibited  a large steady-state  ER pool size (Endo 
H-sensitive form) for the TG protein relative to POMC, and 
thus a  correspondingly ~3-4-fold slower  exit  rate from the 
ER.  Transfer  of TG  protein  out  of the  Golgi  apparatus, 
however,  appeared to be as efficient  as POMC, since TG17 
cells exhibited  a normal relative  pool size for the Golgi form 
(Endo H-resistant)  of the TG protein (Table II). Thus, except 
TABLE II.  Rate of Export of the TG Protein from the ER and the 
Golgi Apparatus 
ER pool  Golgi  Rate con-  Rate con- 
Mole-  size  pool size  stant of  stant of 
cules se-  (Endo H-  (Endo H-  export  export 
Pro-  creted  sensitive  resistant  from the  from the 
rein  per hour  form)  form)  ER  Golgi 
[E]  [G]  kE, h -1  kc, h -1 
TG  100  257  28  0.38  3.5 
POMC  100  74  46  1.35  2.2 
TG17 cells were labeled  with [3SS]methionine for 15 h to reach steady-state 
labeling  of intracellular  ER and Golgi  pools. To measure steady-state  rate of 
secretion,  the medium was removed from the cells and replaced  with a fresh 
aliquot of the identical  media containing [3SS]methionine. Labeled  materials 
secreted  into the medium during the next hour were collected, and the cells 
were extracted with buffers containing detergents  to determine the intracel- 
lular  pool  sizes. Samples  were  immunoprecipitated  with  antisera  against 
either VSV or ACTH, digested  with Endo H, electrophoresed on SDS poly- 
acrytamide  gels, and quantitated by scanning the autoradiograms.  Numbers 
were normalized  to the total amount secreted  into the medium  per hour. 
The amounts of Endo H-sensitive forms of TG or POMC residing  intracellu- 
lady are taken to be a measure of the ER pool, and those resistant to Endo H 
digestion  as the Golgi  pool. The rate constant  of ER export is calculated  by 
dividing the rate of secretion by the size of the ER pool. The rate constant  of 
Golgi export is calculated  by dividing the rate of secretion by the size of the 
Golgi  pool (see Eq. 1, Materials  and Methods). for the slow rate of exiting the ER,  TG  behaved exactly  as 
POMC,  which is secreted constitutively (12).  Similar results 
have been previously obtained with transfected C127 or COS 
cells (8, 24). 
Quantification  of Sorting 
The slow ER exit rate of the TG protein made us wonder 
if the lack of detectable stimulation of its secretion by 8-Br- 
cAMP  (Fig.  3)  could  be  due  to  the  background  of a  high 
constitutive secretion that is chased out slowly. To compare 
sorting independent of the ER pool size, we devised a labeling- 
chase protocol which is explained in the Materials and Meth- 
ods section. In essence, the rate of secretion from the regulated 
pool in comparison with the total rate of secretion at steady- 
state  provides  a  measure of the  efficiency  for entering  the 
regulated  pathway  that  is  independent  of  the  kinetics  of 
constitutive release. 
To measure the total rate of secretion, TGI7  and GHl3/ 
5/4  cells were labeled  with  [3SS]methionine for  16  h  to ap- 
proach steady-state labeling of all intracellular pools.  Mate- 
rials secreted into this medium during the last hour of labeling 
were collected and analyzed. Since [35S]methionine was pres- 
ent  throughout this  time,  the  amount  of labeled  materials 
secreted into the medium is a measure of the steady-state rate 
of secretion rather than the ER pool size. Secretion from the 
regulated secretory granule pool was then measured as follows. 
The labeled cells were first chased with unlabeled medium for 
two 3-h periods to lower the background secretion contributed 
by the constitutive pathway (t,/2 -  30 min-l.5  h). They were 
then stimulated during a third 3-h interval with 5 mM 8-Br- 
cAMP. The difference between secretion from stimulated cells 
and from unstimulated cells during this time was measured 
and compared with the steady-state rate of secretion.  Fig.  5 
shows the comparison of secretion ofhGH and the TG protein 
using this protocol. Even with this long chase protocol, which 
maximizes the detectability of regulated secretion, we could 
not detect  any effect of 8-Br-cAMP on the secretion of the 
TG  protein  (Fig.  5  A).  In  contrast,  stimulation  of growth 
hormone under identical conditions was evident (Fig.  5  B). 
Quantitation of these data is shown in Table IlI, where sorting 
indices  are calculated by  taking the ratio of the  stimulated 
response  to  the  steady-state  rate  of  secretion  (see  Eq.  2, 
Materials and Methods). All peptide hormones examined thus 
far, POMC (endogenous), hGH (exogenous) (Table III), and 
proinsulin (19),  show a  similar partition coefficient into the 
regulated  secretory  granules.  In  contrast,  transport  of TG 
TAaLE III.  Quantitative Comparison of Transport of Secreted 
Proteins  to the Regulated Pathway in AtT-20 Cells 
Amount 
Total  Increment  depleted 
amount  of the  from in- 
secreted/  amount  tracellular 
h in ab-  secreted/  pool/h 
sence of  h in re-  upon 
stimula-  sponse to  stimula-  Sorting 
Protein  tion*  stimulation*  tion  ~  index  N 
X  D'  D'  D'/X 
Endogenous  600 _+ 50  83 +  7  84 _  8  0.14 +_ 0.02 
mouse 
ACTH 
Truncated  31  _+ 6  ~<0.16  ~<0.~3  ~<0.005 
VSV G 
hGH  690 ___ 60  270 _+ 30  220 _+ 30  0.35 ___ 0.06 
The data in Fig. 5 were quantitated by scanning the autoradiogram. 
* Amount secreted during the 1-h labeling period (Fig. 5, lanes 1 and 2). 
* Differences in the amounts secreted from stimulated and unstimulated cells 
during the third chase period (Fig. 5, lane 7 minus lane  8). 
s Differences in the amounts inside stimulated and unstimulated ceils at the 
end of the chase (Fig. 5A, lanes 13 and 14 minus lanes 11 and  12, or Fig. 
5B, lane 11 minus lane 10). 
I The ratio of column 2 to column 1, or column 3 to column 1, according to 
Eq. 2 in Materials and Methods. 
FIGURE  5  Quantification of transport by the two 
pathways. TG 17  or GH 13/5/4  cells were  labeled 
with  [3SS]methionine  for  15  h.  Medium  was  re- 
moved, and a fresh aliquot of the labeling medium 
was  added  for  an  additional hour.  At  time  zero 
indicated in the top axis, cells were chased for two 
consecutive  3-h  periods followed  by  stimulation 
with 5 mM 8-Br-cAMP during the third. (A) Secre- 
tion  of the  TG  protein.  Lanes  1 and  2,  medium 
samples collected during the  1-h  (t =  -1  to 0  h) 
labeling period. Lanes 3 and 4, from the first chase 
period  (t  --  0  to  3  h).  Lanes  5  and  6,  from  the 
second chase period (t =  3 to 6 h). Lanes 7 and 8, 
from  third  chase  period  (t  =  6  to  9  h)  in  the 
presence and  absence of  5  mM  8-Br-cAMP,  re- 
spectively.  Lanes  9  and  10,  intracellular  proteins 
extracted at the end of the labeling (t =  0).  Lanes 
11 and  12, intracellular proteins remaining in cells 
that have been stimulated at the end of the chase 
(t =  9 h) and lanes 13 and 14, in cells that have not 
been stimulated. Samples in  lanes  10,  12, and  14 
were digested with Endo H. (B) Secretion of hGH. 
Lanes  1-8 are the corresponding medium samples 
as described  in A.  Lanes  9-11,  cell  extracts  pre- 
pared  at  the  beginning  of  chase,  at  the  end  of 
chase  from  stimulated  cells,  and  at  the  end  of 
chase from  unstimulated  cells,  respectively. Lane 
12, control ART-20 cells extracted at the end of the 
labeling  period. 
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least 30-fold less efficient (Table III). We conclude that peptide 
hormones are transported to the regulatory secretory pathway 
in  preference  to  other  secreted  proteins,  such  as  the  TG 
protein. 
DISCUSSION 
At  least  three  classes  of proteins,  i.e.,  plasma  membrane, 
lysosomal, and  secretory proteins,  use  a  common site,  the 
rough  ER,  for their  membrane translocation.  Presumably, 
mechanisms exist that sort these proteins from one another 
and target them to their final destinations. This is known to 
be true at least for lysosomal enzymes, which can be selectively 
segregated  by  mannose-6-phosphate  receptors  and  trans- 
ported to the lysosomes in fibroblasts (for review, see reference 
27).  Evidence for active sorting of the other two classes of 
proteins, however, is scant. In hepatocytes, it has been docu- 
mented that the secreted albumin, transferrin, and the mem- 
brane  VSV  G  protein  are  localized  to  the  same  secretory 
vesicle,  suggesting that proteins may not be segregated from 
each  other before reaching the  cell  surface (30).  Similarly, 
temperature-sensitive yeast mutants that are defective in in- 
vertase secretion also cannot externalize some of their plasma 
membrane proteins (21).  A  simple model to  explain these 
observations is that secretory proteins and plasma membrane 
proteins are the only proteins that are neither actively segre- 
gated away from the Golgi lumen (like lysosomal enzymes) 
nor selectively retained (like Golgi enzymes). As a result they 
are  automatically  transported  to  the  cell  exterior  without 
active sorting. 
In cells such  as endocrine cells that have more than one 
type of secretory vesicle, transport to each pathway could also 
be governed by passive flow. Previous work with ART-20 cells 
has established that plasma membrane proteins such as the 
viral glycoprotein gp70 preferentially use the constitutive type 
vesicles for export (12).  The percentage of gp70 taking the 
regulated route is at most one-tenth of that for ACTH. This 
difference  in  the  routes  of transport,  however,  is  not  an 
incontrovertible argument for active sorting. The sizes of the 
two  types  of  vesicles  can  differ,  thus  carrying  different 
amounts of membrane proteins relative to secretory proteins 
to the  cell  surface. For instance, if the  constitutive vesicles 
have a tenth of the diameter of the regulated vesicles,  their 
surface to volume ratio would be ten times higher than for 
the regulated vesicles.  This could result in the apparent  10- 
fold segregation of membrane and secretory proteins. Shape 
differences in the transport vehicles have also been proposed 
to  explain  the  segregation  of ligand  and  receptors  during 
endocytosis (Helenius,  A.,  and  I.  Mellman,  personal com- 
munication). 
The need to examine a passive-flow model was reinforced 
by our DNA transfection experiments. Despite their species 
difference and the lack of apparent sequence homology, hu- 
man proinsulin (19),  hGH (this report), and rat trypsinogen 
(3) are all transported into the regulated secretory vesicles by 
ART-20 cells. This lack of specificity for species or sequence 
could be readily explained if transport were by a nonselective 
bulk-flow process. 
The data presented in this report, however, are difficult to 
reconcile with the passive flow segregation model. Using a 
secreted form rather than the membrane form of the VSV G 
protein, such that the surface to volume ratio is not a concern, 
1780  THE  JOURNAL  OF  CELL BIOLOGY • VOLUME  101,  1985 
we  found that selective transport can still  occur.  A  similar 
conclusion can also be drawn  from analyzing the VSV TG 
protein transfected into HIT (an insulin-producing pancreatic 
cell  line) cells (unpublished observations). Now for the first 
time we can say unequivocally that two known soluble pro- 
teins  introduced  by DNA  transfection  partition  differently 
between two pathways.  Recently, using a  labeling protocol 
identical to that described here, Burgess et al. (3) have shown 
that laminin,  a  naturally occurring secretory protein of the 
AtT-20 cells, is secreted constitutively. Thus, in this cell type 
proteins are actively sorted from one another and targeted to 
specific secretory pathways. 
One hypothesis to explain our data is that both regulated 
and  constitutively  secreted  proteins  contain  active  sorting 
signals and are recognized by individual receptors (1). Alter- 
natively, segregation can be mediated by only one type of 
receptor that specifically recognizes proteins entering either 
the  regulated  pathway  such  as  ACTH,  hGH,  and  human 
insulin, or the constitutive route such as VSV TG. The other 
class of proteins would then be transported to the cell surface 
by  simple  noncarrier-mediated  bulk-flow.  Several  indirect 
lines of evidence led us to suggest  that only entry into the 
regulated  pathway may be carrier mediated.  First,  in  cells 
treated with  /3-D-xyloside to inhibit  proteoglycan synthesis, 
the majority of the glycosaminoglycan chains are efficiently 
exported  via  the  constitutive  pathway  (2).  Since  the  TG 
protein also preferentially takes this route but does not share 
common  chemical  structures,  either  they  both  enter  this 
pathway  by  bulk-flow,  or  they  have  to  be  segregated  by 
different receptors, a possible but less likely situation. Second, 
when targeting to regulated pathway is perturbed by chloro- 
quine, those ACTH molecules that would normally enter the 
regulated secretory granules are diverted to the constitutive 
pathway. Either entry to the latter pathway does not require 
signal(s)  or much less likely,  the constitutive signal is added 
to the diverted ACTH molecules in the presence of chloro- 
quine. Finally, the VSV TG protein might not be expected to 
contain a natural sorting signal as a secretory protein. None- 
theless,  it  is  secreted constitutively.  Direct  proof,  however, 
that sorting signals are contained within the regulated and not 
the constitutive proteins awaits further experimentation. 
Although all peptide hormones that we have examined thus 
far were found to be transported and packaged in the regulated 
secretory granules by AtT-20 cells,  some newly synthesized 
hormones always escape this packaging and are secreted con- 
stitutively. Since sorting is not all-or-none, it must be analyzed 
quantitatively. Since proteins are known to exit ER at differ- 
ent rates (14,  24,  29, and this report), quantitation of sorting 
had  to  be  independent  of export  rates  from  the  ER.  By 
measuring the  ratio  of the  release  rate  from the  regulated 
pathway to total release rate, we can measure sorting inde- 
pendent of the ER exit rate (in Eq. 2, Materials and Methods, 
D'/X is independent of kE). Secondly, since only a vestige of 
the  regulated  pathway remains in  this tumor cell  line,  the 
protocols had to be optimized to be very sensitive to small 
amounts of regulated release.  The accuracy of the measure- 
ments for regulated release was maximized by chasing out 
background constitutive release that had to be subtracted from 
the total. Using this procedure, we are able to detect at least 
a 30-fold discrimination between TG and hGH by the sorting 
apparatus (Table III). It should be emphasized that this is a 
limit measurement and the true partition ratio could be even FIGURE 6 A simple scheme
of partitioning between the
two secretory pathways . k r ,,
k, and kr2, and K,2 are rate
constants, and [G], [R], and
[C] are the concentrations in
the Golgi apparatus, regulated
secretory vesicles, and consti-
tutive secretory vesicles, re-
spectively . When the cell is
stimulated to secrete, the rate
constant kr2 increases to kr2 +
kr2' .
higher . The quantitative measurements also indicate that the
sorting apparatus does not prefer the endogenous ACTH to
the foreign hGH. The preference of the sorting apparatus for
growth hormone may be significant (Table III) .
While the sorting index provides a convenient measure to
compare sorting between different proteins, it is not the true
partition ofGolgi molecules between the two pathways . If the
simple model outlined in Fig. 6 is correct, the true sorting
ratio is related to the sorting index by a proportionality
constant that is a function of the various rate constants (see
Eq . 2) . Ifthese are estimated the true sorting ratio is between
0.15 and 0.30, or only 1 in 3-6 newly synthesized hormone
molecules enters the regulated pathway . Either AtT-20 cells
sort proteins very inefficiently into the regulated pathway, or
a considerable amount ofwhat is sorted is lost before it arrives
in mature secretory vesicles . Loss could be induced by crino-
phagy (6) or by rapid release of the contents of immature
vesicles . An alternative way of interpreting the inefficient
sorting is that AtT-20 cells are rapidly growing, unlike con-
ventional cells, and the doubling ofmembrane area every 25
h requires considerable addition of membrane proteins and
so unusually high constitutive release . Despite the inefficiency
in sorting, the quantitative procedure described here provides
sufficient sensitivity to allow future mapping of sorting se-
quences by in vitro mutagenesis.
If targeting to the regulated secretory granules indeed is
mediated by specific receptors and ifonly one type of receptor
exists, then our observations that several endocrine peptides
enter this pathway at similar efficiencies suggest that these
proteins share a common structural feature . Direct examina-
tion of their primary amino acid sequences revealed no con-
served homology between these proteins . However, the signal
peptides of known proteins, though recognized by the same
signal recognition particle, also lack direct amino acid se-
quence homology . The protein moieties of those lysosomal
enzymes that are selectively recognized by the same enzyme,
N-acetylglucosamine phosphotransferase, also fail to exhibit
consensus amino acid sequence (Kornfeld, S ., unpublished
observations) . Presumably, targeting is mediated by recogni-
tion of a common higher order structure.
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